Australian (ASX) Stock Market Forum

PTX - Prescient Therapeutics

Jump to new
Interesting day for this one.
What gives? No news?

Screenshot_20210602-231906.png
 
frugal.rock said:
Interesting day for this one.
What gives? No news?
Click to expand...

Most likely being Specced on the expected results in the upcoming Quarterly. PTX-200 (higher dose level) and PTX-100 results

They have about $17 million in the bank and still under the $100 mill market cap

You still own this one Rock?


Subsequent to the end of the quarter, the Phase 1b clinical study of PTX-200 and cytarabine in patients with acute myeloid leukemia (AML) successfully completed the second cohort at 35 mg/m2 PTX-200 under the modified study protocol, with no dose limiting toxicities observed. The safe completion of this cohort suggests that AML patients are able to better tolerate the combination of PTX-200 and cytarabine under the modified protocol. As planned, the study has now progressed to the next dose level of 45 mg/m2 PTX-200.

The Phase 1b basket study of PTX-100 in several solid and haematological cancers has recruited patients for the highest dose level of 2,000 mg/m2. As detailed in previous updates, a number of patients remained on the therapy longer than anticipated which has required additional manufacturing. Manufacturing is currently underway and is on schedule. Headline safety results are expected to be reported in the coming quarter
 
....in the article from Aug last year

CAR-T is a new technique for fighting cancer that trains a patient's own immune system to recognise and attack cancer cells that have resisted standard treatments like chemotherapy or radiation. Using this approach, a person's T-cells are extracted and modified outside the body to produce special structures called chimeric antigen receptors (CARs) on their surface. These receptors are able to recognise and latch onto a specific antigen on a patient's tumour cells when they're re-injected into the body, allowing them to destroy the cells.

There's no question in my mind that it's the future. It's weaponising your own cells. Cells are the problem with cancer and they will be the answer. It's the ultimate killing machine, Prescient chief executive Steven Yatomi-Clarke said. We're the only listed company in Australia doing CAR-T... and it will be the next generation cell therapy.
Click to expand...
 
Dona Ferentes said:
....in the article from Aug last year

CAR-T is a new technique for fighting cancer that trains a patient's own immune system to recognise and attack cancer cells that have resisted standard treatments like chemotherapy or radiation. Using this approach, a person's T-cells are extracted and modified outside the body to produce special structures called chimeric antigen receptors (CARs) on their surface. These receptors are able to recognise and latch onto a specific antigen on a patient's tumour cells when they're re-injected into the body, allowing them to destroy the cells.
Click to expand...
This one kept popping up in my systems and so far brought some coins in.. let's see
 
I wouldn't be selling this just yet, making strong gain since the start of June, bio tech business a bit much for me. But its having a good time!

1625639551536.png
 
Attend a special investor briefing with Steven Yatomi-Clarke, CEO and MD of Prescient Therapeutics (PTX), this Wednesday, 21 September at 12pm AEST to find out more about their revolutionary cell therapy CAR-T and the company's flagship technology OmniCAR.

Book your spot here: https://bit.ly/3Ud7Mad
 
Good morning
Excellent SP movement today (09/03/23) currently 23.71%. Announcement attached.
Not holding

Kind regards
rcw1
 

Attachments

  • 2641611.pdf
    893.5 KB · Views: 12
Good afternoon
PTX not really that awe inspiring... maybe, yet....
Interesting times ahead, reckon. Not holding at the minute but have fast traded.

June 2023 1/4erly.

Financials state 2.8 quarters of funding and summary states 10.5 quarters ... ha ha ha ha ha ha Exploring further there is another 16 million not counted by the looks as tied up in fixed term deposits... so, looks to be financial - 10 1/4 erly's.

Testing regimes not entirely sure what to believe... colour of money could get red ha ha ha ha ha
Anyways, PTX is rcw1 nomination for the August 2023 competition. Be there or be square!!!

EDIT: link didn' t work so attached

Kind regards
rcw1
 

Attachments

  • June-2023-Quarterly-Update-and-Appendix-4C.PDF
    6.5 MB · Views: 5
rcw1 said:
Good afternoon
PTX not really that awe inspiring... maybe, yet....
Interesting times ahead, reckon. Not holding at the minute but have fast traded.

June 2023 1/4erly.

Financials state 2.8 quarters of funding and summary states 10.5 quarters ... ha ha ha ha ha ha Exploring further there is another 16 million not counted by the looks as tied up in fixed term deposits... so, looks to be financial - 10 1/4 erly's.

Testing regimes not entirely sure what to believe... colour of money could get red ha ha ha ha ha
Anyways, PTX is rcw1 nomination for the August 2023 competition. Be there or be square!!!

EDIT: link didn' t work so attached

Kind regards
rcw1
Click to expand...
I had a look and felt a bit prescient.?
 
Sticking with PTX for the September 2024 tipping comp. No other reason than this stock kept me in the top 10 tippers for most of August.
 
Top